NAFDAC Bans Registration of Multi-Dose Artemether/Lumefantrine Oral Suspension Due to Safety Concerns

Official Public Notice from NAFDAC The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an important update regarding the safety and regulatory status of Multi-Dose Artemether/Lumefantrine dry powder for oral suspension, a commonly used anti-malarial medication in Nigeria. Following stability testing and product evaluations, NAFDAC has officially discontinued the registration and […]

Carpa Healthcare operational premises approved by Pharmacy Council of Nigeria

Carpa Healthcare Secures Approval from the Pharmacy Council of Nigeria: A Milestone in Quality-Driven Pharmaceutical Operations Introduction: A New Chapter Begins In a major milestone that reaffirms our unwavering dedication to quality, compliance, and public health, Carpa Healthcare is proud to officially announce that our operational premises in Uyo, Akwa Ibom State, has been duly […]